Staff Members

Dr Adam Todd, MPharm PhD MRSC MRPharmS

Member of the Medicine, Pharmacy and Health, School of

Telephone: +44 (0) 191 33 40542

Room number: F118, Wolfson Research Institute, Queen's Campus, Stockton on Tees, TS17 6BH

Lecturer in Pharmacy Practice in Undergraduate Pharmacy

Fellow of the Wolfson Research Institute for Health and Wellbeing

(email at adam.todd@durham.ac.uk)

Biography

Adam Todd is a lecturer in Pharmacy Practice for the Master of Pharmacy (MPharm) programme. The programme, based at Queen’s Campus, is due to start in September 2013; Adam is responsible for developing the work-based learning strategy for the MPharm.

Adam registered as a pharmacist in 2005 after completing his pre-registration training in community pharmacy. After this time, he started a PhD in medicinal chemistry using novel molecular modeling techniques to rationally design agents for the treatment of various inflammatory disorders, which were then prepared and characterized using a wide range of synthetic methodologies.

Once Adam obtained his PhD, he joined the teaching staff at the University of Sunderland as a Senior Lecturer in Pharmacy Practice and Clinical Therapeutics. During his time at Sunderland, Adam was module lead for the pharmacy law and practice element of the MPharm. He also formed part of the MPharm management team and, working alongside the programme director, helped design an integrated pharmacy programme, which was the first in the UK to be accredited to the General Pharmaceutical Council’s new standards of education.

Since 2009, Adam has held an honorary contact with Northumbria Foundation Trust where he has worked closely with the Consultant Pharmacist for Cancer Services to establish a pharmacist-led oral chemotherapy service. His main research interests focus around the theme of cancer and range from using molecular modeling techniques to design new agents for cancer treatment to the rational use of medicines in oncology and palliative care.

Adam works with the General Pharmaceutical Council as a question writer for the pharmacist registration exam. He is a book reviewer for the Pharmaceutical Journal and is currently Editor-in-Chief for the journal Integrated Pharmacy Research and Practice.

Selected Publications

Books: authored

Anderson, R.J, Groundwater, P.W, Todd, A & Worsley, A.J (2012). Antibacterial Agents: Chemistry, Mode of Action, Mechanisms of Resistance and Clinical Applications. Chichester: Wiley-Blackwell.

Books: sections

Todd, A & Husband, A (2013). Managing Chemotherapy-Induced Nausea and Vomiting (CINV) in a patient with Lung Cancer. In Integrated Pharmacy Case Studies. Felicity Smith & Kevin Taylor London: Pharmaceutical Press.
Todd, A & Husband, A (2013). The use of Antimetabolites in the Treatment of Breast Cancer. In Integrated Pharmacy Case Studies. Felicity Smith, & Kevin Taylor London: Pharmaceutical Press.
Todd, A & Husband, A (2013). Treating a Patient with Benign Prostatic Hyperplasia (BPH). In Integrated Pharmacy Case Studies. Felicity Smith, & Kevin Taylor Pharmaceutical Press, London.
Anderson, R.J & Todd, A (2012). Stereochemistry and Drug Action. In Pharmaceutical Chemistry. Barber, J & Rostron, C Oxford Oxford University Press.

Conference papers

Williamson, S, Mahony, M, Baqir, W & Todd, A (2012), Discontinuing non-essential medication in patients taking erlotinib for advanced non-small cell lung cancer, Guild of Healthcare Pharmacy (GHP) and United Kingdom Clinical Pharmacy Assocation (UKCPA) 8th Joint National Conference. Belfast, Ireland.
Po, C.H & Todd, A (2012), Drug Utilization Review of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in Alice Ho Miu Ling Nethersole Hospital (AHNH), Hong Kong Pharmacy Conference. Hong Kong.
Fox, C, Husband, A, Anderson, R.J, Ling, J, Williamson, S & Todd, A (2012), Genotypic Variation and Chemotherapy induced nausea and vomiting, British Oncology Pharmacist Association (BOPA) Conference, 15th Annual Symposium. Harrogate International Centre, Harrogate, UK.
Williamson, S, Mahony, M, Baqir, W & Todd, A (2012), Is there scope to discontinue non-essential medication in patients with advanced lung cancer?, Royal Pharmaceutical Society Conference. ICC, Birmingham, UK.
Jack, C.K.W & Todd, A (2012), The Impact on Blood Pressure Control after Switching from Perindopril to Lisinopril: A Retrospective Crossover Study, Hong Kong Pharmacy Conference. Hong Kong.
Todd, A, Williamson, S & Singh, A (2011), Does the current MPharm programme equip students with the necessary communication skills to successfully manage cancer patients?, British Oncology Pharmacy Association (BOPA) and UK Oncology Nursing Society (UKONS) Joint Conference. Glasgow, UK.
Todd, A & Williamson, S (2010), Clinical pharmacists as advanced practitioners: A qualitative evaluation of communication skills needed by pharmacists to successfully manage cancer patients, British Oncology Pharmacy Association (BOPA) and the UK Oncology Nursing Society (UKONS) Joint Annual Conference 2010. Manchester.
Baqir, W, Todd, A, Learoyd, T, Sim, A & Morton, L (2010), Cost effectiveness of community pharmacy minor ailment schemes, Royal Pharmaceutical Society Conference 2010: Supporting patient and professional decision making. London.

Journal papers: academic

Todd, A, Brierley-Jones, L, Husband, A, Williamson, S, Sarai, I & Ling, J (2013). Be Clear on Cancer: Pharmacy students' views on communicating with cancer patients. Pharmacy Education
Todd, A , Husband, A, Richardson, R, Jassal, N, Robson, P & Andrew, I (2012). Are we using oxycodone appropriately? A utilisation review in a UK tertiary care centre. European Journal of Hospital Pharmacy 0: 1-3.
Husband, A & Todd, A (2012). Benign prostatic hyperplasia: clinical features and diagnosis. Clinical Pharmacist 4: 42-46.
Husband, A & Todd, A (2012). Benign prostatic hyperplasia: management. Clinical Pharmacist 4: 47-50.
Todd, A & Ling, J (2012). Editorial. Integrated Pharmacy Research and Practice 1: 1-2.
Todd, A, Williamson, S, Husband, A, Baqir, W & Mahony, M (2012). Patients with advanced lung cancer: is there scope to discontinue inappropriate medication?. International Journal of Clinical Pharmacy 35(2): 181-184.
Husband, A, Todd, A & Clark, L (2012). Treatment of idiopathic pulmonary fibrosis. Hospital Pharmacy Europe 60: 36-38.
Baqir, W, Learoyd, T, Sim, A & Todd, A (2011). Cost analysis of a community pharmacy 'minor ailment scheme' across three primary care trusts in the North East of England. Journal of Public Health 33(4): 551-555.
Ashton, M & Todd, A (2011). Current research and development of new treatments for schizophrenia. The Pharmaceutical Journal (286): 174-175.
Todd, A, Husband, A & Worsley, A.J (2011). The role of the hedgehog pathway in cancer pathogenesis. Hospital Pharmacy Europe 58: 33-35.
Williamson, S, Todd, A, Anderson, R.J & Groundwater, P.W (2010). Current advances and research in the treatment of pancreatic cancer. The Pharmaceutical Journal 284: 137-138.
Todd, A, Anderson, R.J, Groundwater, P.W & George, S.E (2010). Current and potential new therapies for the treatment of psoriasis. The Pharmaceutical Journal 284: 560-561.
Todd, A, Moore, A, Ashton, M & Van, S (2010). Current research and development of treatments for Alzheimer’s disease. The Pharmaceutical Journal 284: 429-430.
Husband, A, Todd, A & Williamson, S (2010). Managing chemotherapy induced nausea and vomiting. The British Journal of Clinical Pharmacy 2(2): 45-47.
Todd, A, Worsley, A.J & Husband, A (2010). Managing tuberculosis and adverse reactions to treatment. The British Journal of Clinical Pharmacy 2(3): 84-86.
Todd, A, Anderson, R.J, Pickles, G & Groundwater, P.W (2010). Targeting the thioredoxin system in the treatment of certain cancers. The Pharmaceutical Journal 284: 243-244.
Anderson, R.J, Groundwater, P.W, Todd, A & Moore, A (2009). An overview of cancer treatments. The Pharmaceutical Journal 283: 511-512.
Todd, A, Worsley, A.J, Anderson, R.J & Groundwater, P.W (2009). Current research and development into new antibacterial agents. The Pharmaceutical Journal 283: 359-360.
Todd, A, Anderson, R.J & Groundwater, P.W (2009). Rational drug design — designing a molecule that binds to a target. The Pharmaceutical Journal 283(7563): 131-132.
Todd, A, Anderson, R.J & Groundwater, P.W (2009). Rational drug design — identifying and characterising a target. The Pharmaceutical Journal 283(7559): 19-20.
Groundwater, P.W, Todd, A, Worsley, A.J & Anderson, R.J (2009). The technology and techniques used in the detection of pathogenic bacteria. The Pharmaceutical Journal 283(7569): 281-282.

Show all publications

Teaching Groups

Pharmacy